Serina Therapeutics (SER) Invested Capital (2017 - 2025)
Serina Therapeutics (SER) has disclosed Invested Capital for 9 consecutive years, with -$37000.0 as the latest value for Q4 2025.
- Quarterly Invested Capital fell 107.27% to -$37000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$37000.0 through Dec 2025, down 107.27% year-over-year, with the annual reading at -$37000.0 for FY2025, 107.27% down from the prior year.
- Invested Capital hit -$37000.0 in Q4 2025 for Serina Therapeutics, down from $4.5 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $4.5 million in Q3 2025 to a low of -$32.3 million in Q4 2023.
- Historically, Invested Capital has averaged -$10.0 million across 5 years, with a median of -$5.4 million in 2022.
- Biggest five-year swings in Invested Capital: crashed 1472.76% in 2021 and later skyrocketed 132.41% in 2025.
- Year by year, Invested Capital stood at -$4.7 million in 2021, then plummeted by 536.37% to -$30.1 million in 2022, then decreased by 7.05% to -$32.3 million in 2023, then soared by 101.58% to $509000.0 in 2024, then plummeted by 107.27% to -$37000.0 in 2025.
- Business Quant data shows Invested Capital for SER at -$37000.0 in Q4 2025, $4.5 million in Q3 2025, and $1.6 million in Q2 2025.